Dominique Braun
Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland.
Thoueille P, Alves Saldanha S, Schaller F, Choong E, Munting A, Cavassini M, Braun D, Günthard H, Kusejko K, Surial B, Furrer H, Rauch A, Rougemont M, Ustero P, Calmy A, Stoeckle M, Marzolini C, Di Benedetto C, Bernasconi E, Schmid P, Piso R, Andre P, Girardin F, Guidi M, Buclin T, Decosterd L, Swiss HIV Cohort Study S. Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland. Lancet Reg Health Eur 2023; 36:100793.
Dec 13, 2023Real-world trough concentrations and effectiveness of long-acting cabotegravir and rilpivirine: a multicenter prospective observational study in Switzerland.
Dec 13, 2023Lancet Reg Health Eur 2023; 36:100793
Thoueille Paul, Alves Saldanha Susana, Schaller Fabian, Choong Eva, Munting Aline, Cavassini Matthias, Braun Dominique, Günthard Huldyrich F, Kusejko Katharina, Surial Bernard, Furrer Hansjakob, Rauch Andri, Rougemont Mathieu, Ustero Pilar, Calmy Alexandra, Stoeckle Marcel, Marzolini Catia, Di Benedetto Caroline, Bernasconi Enos, Schmid Patrick, Piso Rein Jan, Andre Pascal, Girardin François R, Guidi Monia, Buclin Thierry, Decosterd Laurent Arthur, Swiss HIV Cohort Study SHCS
External validation of the Dat'AIDS score: A risk score for predicting 5-year overall mortality in people living with HIV aged 60 years or older.
Hentzien M, Frossard J, Kouyos R, Prendki V, Damas J, Hofmann E, Braun D, Schmid P, Bernasconi E, Ragozzino S, Efthimiou O, Delpierre C, Allavena C, Bani-Sadr F, Calmy A, Swiss HIV Cohort Study S. External validation of the Dat'AIDS score: A risk score for predicting 5-year overall mortality in people living with HIV aged 60 years or older. HIV Med 2023; 25:72-82.
Aug 24, 2023External validation of the Dat'AIDS score: A risk score for predicting 5-year overall mortality in people living with HIV aged 60 years or older.
Aug 24, 2023HIV Med 2023; 25:72-82
Hentzien Maxime, Frossard Jaromil, Kouyos Roger D, Prendki Virginie, Damas José, Hofmann Eveline, Braun Dominique, Schmid Patrick, Bernasconi Enos, Ragozzino Silvio, Efthimiou Orestis, Delpierre Cyrille, Allavena Clotilde, Bani-Sadr Firouzé, Calmy Alexandra, Swiss HIV Cohort Study SHCS
Risk Factors and Incidence of Sexually Transmitted Infections in the Swiss HIV Cohort Study.
Bosetti D, Mugglin C, Calmy A, Cavassini M, Stöckle M, Braun D, Notter J, Haerry D, Hampel B, Kovari H, Bernasconi E, Wandeler G, Rauch A, Swiss HIV Cohort Study. Risk Factors and Incidence of Sexually Transmitted Infections in the Swiss HIV Cohort Study. Open Forum Infect Dis 2022; 9:ofac592.
Nov 16, 2022Risk Factors and Incidence of Sexually Transmitted Infections in the Swiss HIV Cohort Study.
Nov 16, 2022Open Forum Infect Dis 2022; 9:ofac592
Bosetti Davide G, Mugglin Catrina, Calmy Alexandra, Cavassini Matthias, Stöckle Marcel, Braun Dominique, Notter Julia, Haerry David, Hampel Benjamin, Kovari Helen, Bernasconi Enos, Wandeler Gilles, Rauch Andri, Swiss HIV Cohort Study
Pharmacokinetic parameters and weight change in HIV patients newly switched to dolutegravir-based regimens in SIMPL'HIV clinical trial
Courlet P, Decosterd L, Alves Saldanha S, Guidi M, Limacher A, Schmid P, Günthard H, Smit M, Marinosci A, Cavassini M, Vernazza P, Braun D, Bernasconi E, Stoeckle M, Wandeler G, Sculier D, Barbieux C, Calmy A. Pharmacokinetic parameters and weight change in HIV patients newly switched to dolutegravir-based regimens in SIMPL'HIV clinical trial. Br J Clin Pharmacol 2021
Mar 25, 2021Pharmacokinetic parameters and weight change in HIV patients newly switched to dolutegravir-based regimens in SIMPL'HIV clinical trial
Mar 25, 2021Br J Clin Pharmacol 2021
Courlet Perrine, Decosterd Laurent Arthur, Alves Saldanha Susana, Guidi Monia, Limacher Andreas, Schmid Patrick, Günthard Huldrych F, Smit Mikaela, Marinosci Annalisa, Cavassini Matthias, Vernazza Pietro, Braun Dominique, Bernasconi Enos, Stoeckle Marcel, Wandeler Gilles, Sculier Delphine, Barbieux Charlotte, Calmy Alexandra
Repeated Syphilis Episodes in HIV-Infected Men Who Have Sex With Men: A Multicenter Prospective Cohort Study on Risk Factors and the Potential Role of Syphilis Immunity
Roth J, Battegay M, Kouyos R, Braun D, Bernasconi E, Vernazza P, Cavassini M, Trellu L, Thurnheer M, Lautenschlager S, Balakrishna S, Franzeck F, Swiss HIV Cohort Study (SHCS). Repeated Syphilis Episodes in HIV-Infected Men Who Have Sex With Men: A Multicenter Prospective Cohort Study on Risk Factors and the Potential Role of Syphilis Immunity. Open Forum Infect Dis 2020; 7:ofaa019.
Jan 12, 2020Repeated Syphilis Episodes in HIV-Infected Men Who Have Sex With Men: A Multicenter Prospective Cohort Study on Risk Factors and the Potential Role of Syphilis Immunity
Jan 12, 2020Open Forum Infect Dis 2020; 7:ofaa019
Roth Jan A, Battegay Manuel, Kouyos Roger D, Braun Dominique, Bernasconi Enos, Vernazza Pietro, Cavassini Matthias, Trellu Laurence Toutous, Thurnheer Maria Christine, Lautenschlager Stephan, Balakrishna Suraj, Franzeck Fabian C, Swiss HIV Cohort Study (SHCS)
Impact of Direct-Acting Antivirals on the Burden of HCV Infection Among Persons Who Inject Drugs and Men Who Have Sex With Men in the Swiss HIV Cohort Study
Salazar-Vizcaya L, Rauch A, Béguelin C, Rougemont M, Hoffmann M, Bernasconi E, Stoeckle M, Cavassini M, Braun D, Fehr J, Wandeler G, Swiss HIV Cohort Study. Impact of Direct-Acting Antivirals on the Burden of HCV Infection Among Persons Who Inject Drugs and Men Who Have Sex With Men in the Swiss HIV Cohort Study. Open Forum Infect Dis 2018; 5:ofy154.
Jun 26, 2018Impact of Direct-Acting Antivirals on the Burden of HCV Infection Among Persons Who Inject Drugs and Men Who Have Sex With Men in the Swiss HIV Cohort Study
Jun 26, 2018Open Forum Infect Dis 2018; 5:ofy154
Salazar-Vizcaya Luisa, Rauch Andri, Béguelin Charles, Rougemont Mathieu, Hoffmann Matthias, Bernasconi Enos, Stoeckle Marcel, Cavassini Matthias, Braun Dominique, Fehr Jan, Wandeler Gilles, Swiss HIV Cohort Study
DAA treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers FIB-4 and APRI
Bachofner J, Mullhaupt B, Terziroli Beretta-Piccoli B, Magenta L, Semela D, Fehr J, Moncsek A, Seifert B, Braun D, Baserga A, Künzler-Heule P, Bergamin I, Kröger A, Valli P, Mertens J. DAA treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers FIB-4 and APRI. Liver Int 2016
Sep 28, 2016DAA treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers FIB-4 and APRI
Sep 28, 2016Liver Int 2016
Bachofner Jacqueline A, Mullhaupt Beat, Terziroli Beretta-Piccoli Benedetta, Magenta Lorenzo, Semela David, Fehr Jan, Moncsek Anja, Seifert Burkhardt, Braun Dominique, Baserga Adriana, Künzler-Heule Patrizia, Bergamin Irina, Kröger Arne, Valli Piero V, Mertens Joachim C
Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection
Metzner K, Aubert V, Furrer H, Battegay M, Vernazza P, Cavassini M, Calmy A, Bernasconi E, Weber R, Günthard H, Klimkait T, Yerly S, Böni J, Scherrer A, Preiswerk B, Joos B, von Wyl V, Leemann C, Rieder P, Braun D, Grube C, Kuster H, Swiss HIV Cohort Study. Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection. J Infect Dis 2013; 208:1102-12.
Jul 11, 2013Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection
Jul 11, 2013J Infect Dis 2013; 208:1102-12
Metzner Karin J, Aubert Vincent, Furrer Hansjakob, Battegay Manuel, Vernazza Pietro, Cavassini Matthias, Calmy Alexandra, Bernasconi Enos, Weber Rainer, Günthard Huldrych F, Klimkait Thomas, Yerly Sabine, Böni Jürg, Scherrer Alexandra U, Preiswerk Benjamin, Joos Beda, von Wyl Viktor, Leemann Christine, Rieder Philip, Braun Dominique, Grube Christina, Kuster Herbert, Swiss HIV Cohort Study